Speaker Profile
Biography
Erika is the Designer/Builder/Leader of ONE CANCER PLACE - the Cancer Learning Community. ONE CANCER PLACE is the new destination for a new way of understanding cancer. Our PASSION is for the implementation of universal biomarker testing for all cancer patients at first-line treatment, regardless of staging.
Session Abstract – PMWC 2022 Silicon Valley
The diagnosis, risk stratification, and treatment of cancer have become increasingly personalized. Clinicians utilize novel testing technologies to select targeted therapeutics based on predictive biomarkers. The advent of newer and less invasive approaches to diagnosis such as liquid biopsy is enabling clinicians to better tailor treatment plans for their patients. Novel immunotherapy agents used alone or in combination with other agents may further optimize outcomes for patients with advanced disease. This session will explore the unique challenges that community-based clinicians face in their practice.